In the News

48753 ksm logo_biz3_1.png

KSM Research And Innovation And Genetika+ Partner To Seek AI Solutions For Personalization Of Depression Treatment

US Healthcare Journal

Aug 15, 2022

48753 ksm logo_biz3_1.png

Our new collaborative research with Genetika+, using AI solutions for personalization depression treatment

Doctors Only (in Hebrew)

Aug 8, 2022

48753 ksm logo_biz3_1.png

Dr. Tal Patalon, Head of KSM, in a conversation with Globes about Monkeypox - research angles, Small-Big Data analysis, and preliminary real world data

Globes (in Hebrew)

Jul 25, 2022

48753 ksm logo_biz3_1.png

Our health agreements with Abu Dhabi Health Services Company (SEHA) and G42 Healthcare draw attention in Emirates media

Emirates news

Jun 20, 2022

48753 ksm logo_biz3_1.png

Monkeypox infection in a developed country: A Case Report

DoctorsOnly (in Hebrew)

Jul 11, 2022

48753 ksm logo_biz3_1.png

In Nature: Delta reinfection risk low among unvaccinated children

Nature

Jun 29, 2022

48753 ksm logo_biz3_1.png

in Ynet: A first agreement was signed between Israel and the Emirates on a joint study about vitamin D deficiency (in Hebrew)

Ynet

Jun 30, 2022

48753 ksm logo_biz3_1.png

Walla! coverage of our groundbreaking collaboration with the Emirates (in Hebrew)

Walla!

Jun 30, 2022

48753 ksm logo_biz3_1.png

Health Policy Watch report on our study about the strong immunity among children against COVID-19 after being infected

Health Policy Watch

Jun 24, 2022

48753 ksm logo_biz3_1.png

Our new study on the duration of protection conferred by a previous SARS-CoV-2 infection amongst children and adolescents

News Medical LIfe Sciences

Jun 23, 2022

48753 ksm logo_biz3_1.png

In Israel Hayom: our joint research partnership with PrognomiQ utilizing Maccabi’s Biobank

Israel Hayom

Jun 22, 2022

48753 ksm logo_biz3_1.png

Unique collaboration with PrognomiQ in Early cancer detection

360Dx

Jun 21, 2022

48753 ksm logo_biz3_1.png

The scientific journal Nature Communications published our study today confirming the waning effectiveness of the COVID-19 third dose

Nature communications

Jun 9, 2022

48753 ksm logo_biz3_1.png

Season 2 opening session of our podcast "a matter of life and death" with Dana Weiss in Globes (in Hebrew)

Globes

Jun 2, 2022

48753 ksm logo_biz3_1.png

Published in The BMJ: Effectiveness of the 4th dose of Pfizer's COVID-19 vaccine against infection wanes after 10 weeks, sooner than previous doses.

The BMJ

May 24, 2022

48753 ksm logo_biz3_1.png

N12 coverage of our new cooperation with Bahrain.

N12 (in Hebrew)

May 11, 2022

48753 ksm logo_biz3_1.png

On Ynet: Our strategic agreement with Bahrain continues to make headlines

Ynet (in Hebrew)

May 10, 2022

48753 ksm logo_biz3_1.png

On The Jerusalem Post: KSM-Bahrain collaboration on research

The Jerusalem Post

May 9, 2022

48753 ksm logo_biz3_1.png

On Israel Hayom: Our agreement with Bahrain

Israel Hayom (in Hebrew)

May 6, 2022

48753 ksm logo_biz3_1.png

On Israel Hayom: KSM signed an agreement for joint medical research with Bahrain

Israel Hayom (in Hebrew)

May 6, 2022

48753 ksm logo_biz3_1.png

On YNET: Dr. Tal Patalon, Head of KSM Podcast - sharing her insights on why we are afraid to cope with our end of life

Ynet (in Hebrew)

May 01, 2022

48753 ksm logo_biz3_1.png

SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections

Clinical Infectious Diseases

Apr 05, 2022

48753 ksm logo_biz3_1.png

Published in Ynet: Dr. Tal Patalon, head of KSM, in her new podcast episode featuring Dr. Nader Butto (in Hebrew).

Ynet (in Hebrew)

Mar 30, 2022

48753 ksm logo_biz3_1.png

Our new COVID-19 4th shot study continues to make headlines. Published today in Haaretz.

Haaretz (in English)

Mar 28, 2022

48753 ksm logo_biz3_1.png

Our Deputy Head Dr. Sivan Gazit on Channel 13 evening news (in Hebrew), refers to our new Covid-19 study.

Channel 13 news (in Hebrew)

Mar 27, 2022

48753 ksm logo_biz3_1.png

This evening in Kan11 news: Our new COVID-19 preprint - The 4th dose of the BNT162b2 vaccine provides at least 73% protection against SARS-CoV-2 severe illness relative to three doses, during the 9 week outcome period.

Kan11 (in Hebrew)

Mar 26, 2022

48753 ksm logo_biz3_1.png

Published in Globes, our collaboration in genetic research with the United Arab Emirates.

Globes (in Hebrew)

Mar 9, 2022

48753 ksm logo_biz3_1.png

Published today in Nature Communications: Waning of SARS-CoV-2 booster viral-load reduction effectiveness

Nature

Mar 4, 2022

48753 ksm logo_biz3_1.png

First collaboration in genetic research between Israel and the United Arab Emirates.

Arabian Business

Mar 2, 2022

48753 ksm logo_biz3_1.png

Published in Science: Minimizing treatment-induced emergence of antibiotic resistance in bacterial infections

Science

Feb 27, 2022

48753 ksm logo_biz3_1.png

We are live! Check out our NEW PODCAST “A matter of life and death”

(In Hebrew)

Feb 16, 2022

48753 ksm logo_biz3_1.png

Today on N12:
Our new research published today in Annals of Internal Medicine exploring hybrid immunity demonstrated a 82% decreased risk of reinfection among persons who were previously infected and then vaccinated compared to those who were previously infected but remained unvaccinated.

N12 (in Hebrew)

Feb 15, 2022

48753 ksm logo_biz3_1.png

Today in Annals of Internal Medicine: exploring hybrid immunity demonstrated a 82% decreased risk of reinfection among persons who were previously infected and then vaccinated compared to those who were previously infected but remained unvaccinated.

Annals of Internal Medicine

Feb 15, 2022

48753 ksm logo_biz3_1.png

Published in Haretz newspaper: our publication "Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes"

Haretz (In Hebrew)

Feb 11, 2022

48753 ksm logo_biz3_1.png

Published in Jama Pediatrics today:
Association of BNT162b2 COVID-19 Vaccination During Pregnancy With Neonatal and Early Infant Outcomes

Jama Pediatrics

Feb 10, 2022

48753 ksm logo_biz3_1.png

Published in Science today: Our new joint study in collaboration with Yale “Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel”

Science

Jan 27, 2022

48753 ksm logo_biz3_1.png

We are excited to share that Galit Perez, head of our clinical trials department, was chosen by Globes magazine to the annual list of 40 under 40 most promosing leaders Copy

Globes (In Hebrew)

January 31, 2022

48753 ksm logo_biz3_1.png

Published today: “Waning of SARS-CoV-2 booster viral-load reduction effectiveness."
The results of new research conducted in collaboration with the Technion

Linkedin

Dec 31, 2021

48753 ksm logo_biz3_1.png

Last call for submissions to our 2022 grant program!
Proposals accepted by the committee will be granted awards up to 400.000 NIS.
For more details, please find the submission form below.

Dec 9, 2021

48753 ksm logo_biz3_1.png

Our new study published today in JAMA "Odds of Testing Positive for SARS-CoV-2 Following Receipt of 3 vs 2 Doses of the BNT162b2 mRNA Vaccine"

Jama Network

Dec 1, 2021

48753 ksm logo_biz3_1.png

We’re super excited with our Deputy Head of KSM Dr Sivan Gazit for making it into the TheMarker “40 under 40” most promising list.

TheMarker(In Hebrew)

Nov 8, 2021

48753 ksm logo_biz3_1.png

Nature Communications published today our study "Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine".

Nature Communications

Nov 4, 2021

48753 ksm logo_biz3_1.png

Nature Medicine magazine published today our joint study with Technion institute: "Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2".

Nature Medicine

Nov 2, 2021

48753 ksm logo_biz3_1.png

Published today on Haaretz newspaper:  Our joint preprint with Technion institute: "Viral loads of Delta-variant SARS-CoV2 breakthrough infections following vaccination and booster with the BNT162b2 vaccine"

Haaretz (In Hebrew)

Sep 19, 2021

48753 ksm logo_biz3_1.png

Published on Ynet- Our preprint “Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine”

ynet (In Hebrew)

Sep 3, 2021

48753 ksm logo_biz3_1.png

Published today on Doctorsonly.
Our preprint: "Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections"

Doctorsonly (in Hebrew)

Sep 2, 2021

48753 ksm logo_biz3_1.png

Published today in Science magazine: our preprint "Short Term Reduction in the Odds of Testing Positive for SARS-CoV-2; a Comparison Between Two Doses and Three doses of the BNT162b2 Vaccine"

Science

September 1, 2021

48753 ksm logo_biz3_1.png

Published today in Science magazine: our preprint "Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections"

Science

Aug 27, 2021

48753 ksm logo_biz3_1.png

New collaboration with Ibex - introducing the world first AI powered solution for gastrointestinal cancer diagnosis at Maccabi Healthcare Services.

AIthority

Aug 25, 2021

48753 ksm logo_biz3_1.png

Nature News new story - our study assessing the correlation between time-from-vaccine and incidence of breakthrough infection in Nature News. We found that Individuals who were vaccinated in January 2021 had a 2.26-fold increased risk for breakthrough infection compared to individuals who were vaccinated in April 2021

Nature.com

Aug 5, 2021

48753 ksm logo_biz3_1.png

Our joint research with Tel Aviv University published in JAMA closed an important knowledge gap on the safety and effectiveness of the COVID-19 vaccine, by examining the pregnant population which was excluded from the clinical trials.

Ynet

July 25, 2021

48753 ksm logo_biz3_1.png

Just published in Reuters Health - Our new study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD)

Reuters Health

July 18, 2021

48753 ksm logo_biz3_1.png

Our study on COVID-19 vaccine effectiveness in patients with Inflammatory Bowel Disease (IBD), published July 2, 2021 in Gastroenterology—the flagship journal of the American Gastroenterology Association.

Gastroenterolgy

July 2, 2021

48753 ksm logo_biz3_1.png

Published today in Doctorsonly

Linkedin

June 13, 2021

48753 ksm logo_biz3_1.png

KSM study in the New York Times!
Our academia-healthcare collaboration with Technion Institute of Technology appearing in the New York Times.
The study "Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals" just published.

New York Times

June 11, 2021

48753 ksm logo_biz3_1.png

Our joint research with Prof. Roy Kishony and his team from Technion Institute "Community-level evidence for Coronavirus vaccine protection of unvaccinated individuals" published today on Nature Medicine Magazine.

Nature Medicine Magazine

June 10, 2021

48753 ksm logo_biz3_1.png

A new research by KSM shows most respondents are in favor of vaccinating 12-16 year olds— men more in favor than women. Furthermore, new insights on additional vaccine doses, mask usage stats and more are described.

Doctors Only ( In Hebrew).

June 6, 2021

48753 ksm logo_biz3_1.png

New KSM research in association with IBM:
Trends in clinical characteristics of severe non-respiratory events related to Coronavirus patients

Linkedin

Apr 18, 2021

48753 ksm logo_biz3_1.png

Our new survey on behaviour attitudes towards preventive measures following Coronavirus vaccination

Linkedin

Apr 14, 2021

48753 ksm logo_biz3_1.png

A new KSM study shows that the rate of children diagnosed with celiac disease in Israel has increased almost threefold over a decade

Ynet (In Hebrew)

Mar 25, 2021

48753 ksm logo_biz3_1.png

Continuing to monitor vaccinated members - 62 days following the first vaccine dose

Linkedin

Mar 11, 2021

48753 ksm logo_biz3_1.png

Our new study on Coronavirus reinfection published today on DoctorsOnly

Doctors Only (In Hebrew)

Mar 10, 2021

48753 ksm logo_biz3_1.png

KSM is publishing a new real world data study on reinfected Maccabi members

Linkedin

Mar 09, 2021

48753 ksm logo_biz3_1.png

A retrospective analysis of serological data in 116 Israeli healthcare workers administered with the Coronavirus vaccine

Linkedin

Mar 07, 2021

48753 ksm logo_biz3_1.png

Continuing to monitor vaccinated members. Coronavirus update February 18

Linkedin

Feb 18, 2021

48753 ksm logo_biz3_1.png


KSM is calling for research proposals

Linkedin (In Hebrew)

Feb 16, 2021

48753 ksm logo_biz3_1.png


We're hiring data scientists

Linkedin

Feb 11, 2021

48753 ksm logo_biz3_1.png


Continuing to monitor vaccinated members at Maccabi

Linkedin

Feb 10, 2021

48753 ksm logo_biz3_1.png

continuing to monitor vaccinated members at Maccabi

Linkedin

Feb 01, 2021

48753 ksm logo_biz3_1.png

New analysis 28 days after the first vaccination dose

Linkedin

Feb 01, 2021

48753 ksm logo_biz3_1.png

KSM publishes world’s first scientific article on effectiveness of Coronavirus vaccine 13-24 days after 1st dose: real world evidence

LinkedIn

Jan 31, 2021

48753 ksm logo_biz3_1.png

KSM - Maccabi Research and Innovation Center - publishes insights from real-time monitoring of Corona virus vaccination data.

LinkedIn

Jan 22, 2021

48753 ksm logo_biz3_1.png


COVID-19: World's first analysis of vaccine data by KSM

Channel 12 News (In Hebrew)

Jan 12, 2021

48753 ksm logo_biz3_1.png

COVID-19 Research: KSM has found that diagnosed depression and obesity increases the risk of coronavirus complications among the young population

Israel HaYom

Jan 07, 2021

48753 ksm logo_biz3_1.png

World's first AI-solution for primary diagnosis of breast cancer deployed by IBEX and KSM

The Jerusalem Post

Dec 16, 2020

48753 ksm logo_biz3_1.png

KSM Research & Innovation Launched a New Health Gaming Program

Ctech by Calcalist

Dec 07, 2020

48753 ksm logo_biz3_1.png

Illnesses Prediction and Home Hospitalization: Vision of the Head of KSM, Dr. Tal Patalon

Globes

Dec 01, 2020

48753 ksm logo_biz3_1.png


Winners of the KSM Health Play Zone Sprint

Linkedin

Nov 01, 2020

48753 ksm logo_biz3_1.png

KSM's Research Claims:
Children are Significant Carriers of Covid-19

Ynet

Oct 16, 2020